CD163 and B-cell chronic lymphocytic leukemia: Flow cytometry analysis was used to validate the cell surface expression of these proteins on the membrane of CLL cells, CD19+ CD5+ gated cells obtained from PBMC from 10 CLL patients and of NLC, CD163+ CD68+ gated cells from a 14 days culture of the same patient's PBMC.